SGK1 and Stroke: In ischemic stroke studies, injection of GSK650394 attenuates neuronal death and blood-brain barrier damage by ischemic stroke (Lee et al., 2020), and administration of AAV-SGK1-shRNA also alleviates neuroinflammation caused by stroke (Chi et al., 2021).